You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Active, not recruiting
  • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-11-08
Nov 8, 2021
T
Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
2021-07-25
Jul 25, 2021
G
Completed
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
2021-08-24
Aug 24, 2021
M
Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
2022-01-07
Jan 7, 2022
N
Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
2021-11-05
Nov 5, 2021
S
Not yet recruiting
  • Myelofibrosis
  • Jaktinib Hydrochloride Tablet
  • (no location specified)
2022-03-03
Mar 3, 2022
N
Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
2021-09-06
Sep 6, 2021
F
Active, not recruiting
  • Myelofibrosis
  • Tours, France
    FILO French Innovative Leukemia Organization
2021-07-19
Jul 19, 2021
N
Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
2022-01-18
Jan 18, 2022
I
Completed
  • Myelofibrosis
  • +3 more
  • Ann Arbor, Michigan
  • +4 more
2022-03-28
Mar 28, 2022
U
Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
2021-09-27
Sep 27, 2021
S
Recruiting
  • Myelofibrosis
  • +3 more
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
2021-06-11
Jun 11, 2021
N
Terminated
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
2021-07-09
Jul 9, 2021
J
Active, not recruiting
  • Primary Myelofibrosis
  • +4 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
2021-05-19
May 19, 2021
M
Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2021-10-30
Oct 30, 2021
N
Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
2021-03-02
Mar 2, 2021
L
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Farmington Hills, Michigan
  • +1 more
2021-06-05
Jun 5, 2021
M
Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
2022-01-04
Jan 4, 2022
M
Recruiting
  • Myelofibrosis Transformation in Essential Thrombocythemia
  • +2 more
  • Elotuzumab
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
2021-02-17
Feb 17, 2021